The market may feel quiet today, but the underlying structure, steady demand, normalized production and persistent biological risk suggest this reset phase is more about recalibration than weakness heading deeper into the first quarter


The market may feel quiet today, but the underlying structure, steady demand, normalized production and persistent biological risk suggest this reset phase is more about recalibration than weakness heading deeper into the first quarter